Acne Vulgaris, the Complete Guide

What it is

Acne vulgaris is a chronic inflammatory condition of the pilosebaceous unit, the structure made up of a hair follicle and its attached sebaceous gland. It is the most common skin condition in dermatology and affects roughly 85% of people between the ages of 12 and 24, with a substantial fraction continuing or developing acne into adulthood.

Four interacting drivers produce the visible lesions: excess sebum production (often androgen-driven), abnormal keratinocyte shedding inside the follicle (hyperkeratinization), proliferation of Cutibacterium acnes (a normal commensal), and inflammatory cascade activation that turns silent comedones into visible papules, pustules, nodules, and cysts.

The lesion types

• Open comedones (blackheads), follicles plugged with oxidized keratin and sebum.
• Closed comedones (whiteheads), same plug, but the follicle remains closed at the surface.
• Papules, small, red, inflamed bumps without visible pus.
• Pustules, papules with a visible white head of neutrophils.
• Nodules, deeper, painful, palpable inflammatory lesions.
• Cysts, large, fluid-filled, deep lesions; the highest scarring risk.

Subtypes worth distinguishing

• Comedonal acne, predominantly non-inflammatory, blackheads/whiteheads.
• Inflammatory acne, papules and pustules dominate.
• Cystic / nodulocystic acne, deep, painful lesions; high scarring risk.
• Hormonal acne, jawline pattern, deep, premenstrual; see the Hormonal Acne deep dive.
• Fungal acne (Malassezia folliculitis), uniform pustules, often on chest/back; not technically acne.
• Acne mechanica, friction-driven, often from masks or equipment.

What research supports, over-the-counter

• Benzoyl peroxide (2.5–5%), gold-standard topical antimicrobial; research suggests no resistance development.
• Salicylic acid (0.5–2%), keratolytic, lipid-soluble; reaches the follicle.
• Adapalene 0.1%, the only over-the-counter retinoid in the US; addresses comedonal and inflammatory components.
• Azelaic acid 10–15% (some up to 20% prescription), anti-inflammatory, anti-microbial, pigmentation support.
• Niacinamide (4–5%), research suggests modest improvement in inflammatory acne.
• Sulfur (3–10%), keratolytic and antibacterial.

What research supports, prescription (dermatology conversation)

• Tretinoin, tazarotene, trifarotene, stronger retinoids than adapalene.
• Topical antibiotics (clindamycin) usually paired with benzoyl peroxide to limit resistance.
• Oral antibiotics (doxycycline) for moderate-to-severe inflammatory acne, time-limited.
• Spironolactone, anti-androgen for hormonal acne in women.
• Combined oral contraceptives, FDA-approved formulations for acne.
• Isotretinoin, for severe, scarring, or treatment-resistant nodulocystic acne.

Lifestyle factors with credible evidence

• Low-glycemic-load diet, consistent association with reduced acne severity.
• Reducing skim milk intake, repeated cohort associations.
• Sleep adequacy, connected to hormonal regulation.
• Stress regulation, cortisol drives sebum production.
• Non-comedogenic sunscreen daily, UV worsens post-inflammatory pigmentation.

What does not help (and may hurt)

• Aggressive over-cleansing, strips barrier, increases reactive sebum.
• Physical scrubs on inflamed lesions, worsens inflammation, risks scarring.
• Toothpaste, lemon juice, baking soda 'spot treatments', high pH, irritant.
• Picking and squeezing, direct cause of post-inflammatory hyperpigmentation and scarring.

Timeline

Most acne protocols take 6 to 8 weeks for measurable visible improvement, with peak effect at 3 to 6 months. Initial worsening ('purging') is possible with retinoids and chemical exfoliants and typically resolves within 4 to 6 weeks. Acne is chronic; ongoing maintenance is the rule, not the exception. Research suggests early intervention reduces long-term scarring risk substantially.